Ultragenyx Pharma (RARE) PT Raised to $48 at Wedbush
Tweet
Share
E-mailGet Alerts RARE Hot Sheet
Price: $26.86 -0.37%
Rating Summary:
21 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
21 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Wedbush analyst Laura Chico raised the price target on Ultragenyx Pharma (NASDAQ: RARE) to $48.00 (from $47.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG
- Vera Therapeutics (VERA) PT Lowered to $80 at Goldman Sachs
- Toei co Ltd (9605:JP) PT Raised to JPY6,100 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
